Seizures associated with idiopathic epilepsy are a serious and life-threatening condition in dogs.
ACI is currently enrolling patients in a prospective, randomized, placebo-controlled, multicenter clinical trial to evaluate the safety and effectiveness of an investigational oral therapy for the control of seizures in treatment naïve dogs with idiopathic epilepsy.
Funding
This is a fully funded study.
Are you an Owner interested in enrolling your dog?
Are you a Veterinarian interested in your clinic participating?
Owner Participation / Commitment
- Owners must be willing to commit to the study visit schedule over a 168-day duration.
- Owners will be required to give their dog study medication twice a day and record in their Owner Dosing Log.
- Owners must monitor their dog for seizures, record all seizures in an Owner Diary, and report all seizures to the Study Veterinarian.
Eligibility
- Dogs must weigh ≥ 6.5 kg.
- Dogs must be ≥ 6 months and < 6 years of age.
- Dogs must have a minimum of three generalized seizures (tonic-clonic, tonic, clonic, atonic, myoclonic) during the Screening Period.
- Dogs must be screened by a Study Veterinarian within 6 months of the initial onset of seizure-like activity.
The Veterinary Investigator at the study site will determine if your pet meets other eligibility criteria and may enroll in the study.
Study Sites
Coming soon